These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9822641)

  • 1. Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells.
    Doré JJ; Edens M; Garamszegi N; Leof EB
    J Biol Chem; 1998 Nov; 273(48):31770-7. PubMed ID: 9822641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
    Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
    J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers.
    Stockwell BR; Schreiber SL
    Curr Biol; 1998 Jun; 8(13):761-70. PubMed ID: 9651680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct endocytic responses of heteromeric and homomeric transforming growth factor beta receptors.
    Anders RA; Arline SL; Doré JJ; Leof EB
    Mol Biol Cell; 1997 Nov; 8(11):2133-43. PubMed ID: 9362058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of transforming growth factor-beta receptor endocytosis and intracellular sorting differ between fibroblasts and epithelial cells.
    Doré JJ; Yao D; Edens M; Garamszegi N; Sholl EL; Leof EB
    Mol Biol Cell; 2001 Mar; 12(3):675-84. PubMed ID: 11251079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential requirement for type I and type II transforming growth factor beta receptor kinase activity in ligand-mediated receptor endocytosis.
    Anders RA; Doré JJ; Arline SL; Garamszegi N; Leof EB
    J Biol Chem; 1998 Sep; 273(36):23118-25. PubMed ID: 9722540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling activity of homologous and heterologous transforming growth factor-beta receptor kinase complexes.
    Vivien D; Attisano L; Wrana JL; Massagué J
    J Biol Chem; 1995 Mar; 270(13):7134-41. PubMed ID: 7706250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region.
    Wieser R; Attisano L; Wrana JL; Massagué J
    Mol Cell Biol; 1993 Dec; 13(12):7239-47. PubMed ID: 8246946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
    Cárcamo J; Weis FM; Ventura F; Wieser R; Wrana JL; Attisano L; Massagué J
    Mol Cell Biol; 1994 Jun; 14(6):3810-21. PubMed ID: 8196624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
    Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human transforming growth factor-beta type II receptor that contains an insertion in the extracellular domain.
    Hirai R; Fijita T
    Exp Cell Res; 1996 Feb; 223(1):135-41. PubMed ID: 8635485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta.
    Saitoh M; Nishitoh H; Amagasa T; Miyazono K; Takagi M; Ichijo H
    J Biol Chem; 1996 Feb; 271(5):2769-75. PubMed ID: 8576253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.
    Feng XH; Derynck R
    EMBO J; 1997 Jul; 16(13):3912-23. PubMed ID: 9233801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture.
    Yamamoto H; Ueno H; Ooshima A; Takeshita A
    J Biol Chem; 1996 Jul; 271(27):16253-9. PubMed ID: 8663151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GS domain of the transforming growth factor-beta type I receptor is important in signal transduction.
    Franzén P; Heldin CH; Miyazono K
    Biochem Biophys Res Commun; 1995 Feb; 207(2):682-9. PubMed ID: 7864860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad7 differentially regulates transforming growth factor beta-mediated signaling pathways.
    Zhu HJ; Iaria J; Sizeland AM
    J Biol Chem; 1999 Nov; 274(45):32258-64. PubMed ID: 10542264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function of the type V transforming growth factor beta receptor in transforming growth factor beta-induced growth inhibition of mink lung epithelial cells.
    Liu Q; Huang SS; Huang JS
    J Biol Chem; 1997 Jul; 272(30):18891-5. PubMed ID: 9228067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric granulocyte/macrophage colony-stimulating factor/transforming growth factor-beta (TGF-beta) receptors define a model system for investigating the role of homomeric and heteromeric receptors in TGF-beta signaling.
    Anders RA; Leof EB
    J Biol Chem; 1996 Sep; 271(36):21758-66. PubMed ID: 8702972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses.
    Itoh S; Thorikay M; Kowanetz M; Moustakas A; Itoh F; Heldin CH; ten Dijke P
    J Biol Chem; 2003 Feb; 278(6):3751-61. PubMed ID: 12446693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
    Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.